The AAHKS Clinical Research Award: Prophylactic Tamsulosin (cas 106133-20-4) Does Not Reduce the Risk of Urinary Retention Following Lower Extremity Arthroplasty: A Double-Blinded Randomized Controlled Trial

Add time:07/22/2019    Source:sciencedirect.com

BackgroundPostoperative urinary retention (POUR) is common. Selective alpha-1 adrenergic antagonists, such as Tamsulosin (cas 106133-20-4), are effective for treating urinary retention. The purpose of this study is to determine whether perioperative prophylactic tamsulosin reduces the incidence of POUR following total hip and knee arthroplasty.

We also recommend Trading Suppliers and Manufacturers of Tamsulosin (cas 106133-20-4). Pls Click Website Link as below: cas 106133-20-4 suppliers

Prev:Hydroxamic acid and fluorinated derivatives of valproic acid: Anticonvulsant activity, neurotoxicity and teratogenicity
Next:Tamsulosin (cas 106133-20-4) attenuates abdominal aortic aneurysm growth)